SARS-CoV-2 Mpro-IN-15

SARS-CoV-2 Mpro-IN-15

• UNSPSC Description: SARS-CoV-2 Mpro-IN-15 (8E) is a SARS-CoV-2 Mpro inhibitor, with an IC50 of  0.606 µM[1].
• Target Antigen: SARS-CoV
• Type: Reference compound
• Related Pathways: Anti-infection
• Applications: COVID-19-anti-virus
• Field of Research: Infection; Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/sars-cov-2-mpro-in-15.html
• Smiles: COC([C@@H](NC(C[C@@H]([C@@H](NC(OC(C)(C)C)=O)CC1=CC=CC=C1)OC(C)=O)=O)CC2=CC=CC=C2)=O
• Molecular Weight: 512.59
• References & Citations: [1]Pedro Henrique R de A Azevedo, et al. Statine-based peptidomimetic compounds as inhibitors for SARS-CoV-2 main protease (SARS-CoV‑2 Mpro). Sci Rep. 2024 Apr 18;14(1):8991.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported